Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Pentetic Acid × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Blast Crisis 1

Interventions

pegaspargase 4 tislelizumab 1 sugemalimab 1 relatlimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Therapeutics 1 Tacrolimus 1 Radiotherapy 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methylprednisolone 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclophosphamide 1 Busulfan 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡